Signaling Pathway
Frunevetmab (NV-02) is a felinized monoclonal antibody targeting nerve growth factor (NGF) with a dissociation constant (Kd) of 20 pM, indicating high affinity for its antigen. This antibody has been shown to effectively reduce osteoarthritis-related pain in feline models, making it a valuable tool for research into pain management and degenerative joint diseases in cats.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Frunevetmab (NV-02) is a felinized monoclonal antibody targeting nerve growth factor (NGF) with a dissociation constant (Kd) of 20 pM, indicating high affinity for its antigen. This antibody has been shown to effectively reduce osteoarthritis-related pain in feline models, making it a valuable tool for research into pain management and degenerative joint diseases in cats. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
